Dmitry SamarskyChief Technology Officer at GALCONDA THERAPEUTICSSpeaker
Agenda Sessions
KEYNOTE PANEL: Bridging the Gap: Addressing Regulatory Challenges in Oligonucleotide Development
, 9:10amView Session